BeStock  
Stocks › Biotechnology › NAMS

NewAmsterdam Pharma NAMS

US equityMarket cap rank #2621Biotechnology
$18.41 −$1.10 (-5.64%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $18.32 -0.49%
Open$19.21
Prev close$19.51
Day range$18.29 – $19.78
Volume1.75M
Market cap$2.21B
P/E (TTM)–
Dividend yield–

Analyst view

ConsensusBuy
Analysts10
Average target$54.44+195.7% vs. price
  • Buy 100%
Low $42.00Now $18.41Avg $54.44High $61.00

Recent rating changes

The last 20 actions on file set price targets from $42.00 to $61.00, averaging $52.88.

DateFirmRatingTarget
10 Nov 2026 Cantor Fitzgerald BUY $61.00
9 Nov 2026 Piper Sandler BUY $60.00
9 Nov 2026 Stifel BUY $50.00
6 Nov 2026 H.C. Wainwright BUY $52.00
5 Nov 2026 Wells Fargo BUY $55.00
5 Nov 2026 BMO Capital BUY $58.00
4 Nov 2026 RBC Capital BUY $42.00
15 Oct 2026 Citi BUY $55.00
5 Oct 2026 RBC Capital BUY $42.00
2 Oct 2026 Wells Fargo BUY $55.00
29 Sep 2026 H.C. Wainwright BUY $52.00
22 Sep 2026 Truist Financial BUY $57.00
21 Sep 2026 BMO Capital BUY $58.00
21 Sep 2026 H.C. Wainwright BUY $52.00
18 Sep 2026 William Blair BUY –
8 Sep 2026 Truist Financial BUY –
8 Sep 2026 Stifel BUY $50.00
8 Sep 2026 H.C. Wainwright BUY $52.00
7 Aug 2026 Needham BUY $48.00
6 Aug 2026 Truist Financial BUY –

Discussion

No comments yet — be the first to weigh in on NAMS.

Sign in to join the discussion.

Scroll to Top